Vimarsana
Biggest News Aggregation in the World

Page 9 - Dee Smith News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dee Smith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dee Smith Today - Breaking & Trending Today

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06.05.2023 - CAMBRIDGE, Mass., May 05, 2023 (GLOBE NEWSWIRE) - Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that the ...

Carson City's Year in Review: a look back on 2020 (pandemic free edition) | Carson City Nevada News - Vimarsana News

Carson City's Year in Review: a look back on 2020 (pandemic free edition) | Carson City Nevada News

It was an eventful year around the Carson City region notwithstanding the limitations caused by the COVID-19 pandemic. Here's some notable stories that were not pandemic related that happened in 2020.

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq - Vimarsana News

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq

CAMBRIDGE, Mass., April 07, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on...

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., April 07, 2023 -- Fulcrum Therapeutics, Inc.® , a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases,... | June 20, 2023

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10.02.2023 - CAMBRIDGE, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) - Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that the ...